Kirn David 4
4 · 4D Molecular Therapeutics, Inc. · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Kirn David
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-02-08$27.13/sh−92,001$2,495,822→ 1,059,153 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023.
- [F2]The transaction was executed in multiple trades in prices ranging from $26.75 to $27.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.